![Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group](https://www.frontiersin.org/files/Articles/583050/fonc-10-583050-HTML-r1/image_m/fonc-10-583050-g001.jpg)
Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group
![Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-64579-z/MediaObjects/41598_2020_64579_Fig3_HTML.png)
Predicting worse survival for newly diagnosed T cell lymphoma based on the decreased baseline CD16−/CD16 + monocyte ratio | Scientific Reports
![A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials? - Jakobsen - Annals of Lymphoma A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials? - Jakobsen - Annals of Lymphoma](https://cdn.amegroups.cn/journals/ales/files/journals/30/articles/6326/public/6326-PB6-3029-R1.png/w300)
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials? - Jakobsen - Annals of Lymphoma
![Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/031bdff7-5f7e-4aeb-8b88-aca6898623f2/cam43037-fig-0001-m.jpg)
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library
![Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine](https://www.thelancet.com/cms/attachment/ec2560c7-dc8d-4a26-90d6-6bffdd934fbd/gr1_lrg.jpg)
Prognostic nomogram incorporating inflammatory cytokines for overall survival in patients with aggressive non-Hodgkin's lymphoma - eBioMedicine
![Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram](https://www.researchgate.net/publication/230723995/figure/fig2/AS:406903982182406@1474024877754/Overall-survival-of-patients-with-stage-I-follicular-lymphoma-in-the-National-LymphoCare.png)
Overall survival of patients with stage I follicular lymphoma in the... | Download Scientific Diagram
![Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-020-00340-z/MediaObjects/41408_2020_340_Fig2_HTML.png)
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal
![Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network | British Journal of Cancer Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.94/MediaObjects/41416_2015_Article_BFbjc201594_Fig1_HTML.jpg)
Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network | British Journal of Cancer
![Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis](https://www.frontiersin.org/files/Articles/588314/fonc-10-588314-HTML/image_m/fonc-10-588314-g001.jpg)
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis
![Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy](https://www.mdpi.com/diagnostics/diagnostics-07-00026/article_deploy/html/images/diagnostics-07-00026-g001.png)
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy
![Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram Progression-free survival and overall survival rates of DLBCL patients,... | Download Scientific Diagram](https://www.researchgate.net/publication/294256802/figure/fig1/AS:560859506110464@1510730734564/Progression-free-survival-and-overall-survival-rates-of-DLBCL-patients-according-to.png)